Panelists discuss how evidence-based, patient-tailored guideline adherence enhances long-term schizophrenia outcomes.
Panelists discuss how the latest APA guidelines advocate a multimodal approach combining pharmacologic treatment with psychosocial interventions such as cognitive-behavioral therapy and supported employment.
Panelists discuss how adherence, monitoring of adverse effects, and collaborative care are emphasized as pillars of sustained stability. Clinicians are encouraged to adapt evidence-based strategies to individual patient profiles.
Panelists discuss how guideline adherence improves outcomes, but flexibility is required to tailor interventions to patients’ unique needs, comorbidities, and cultural contexts.
HEDIS Glycemic Goal Achieved Using Control-IQ Technology
December 22nd 2025A greater proportion of patients with type 1 diabetes who used automated insulin delivery systems vs multiple daily injections achieved the Healthcare Effectiveness Data and Information Set (HEDIS) glycemic measure.
Read More